Literature DB >> 11765377

Monoclonal antibody-based therapy of neuroblastoma.

N K Cheung1, B H Kushner, K Kramer.   

Abstract

The curative potential of mAbs in the treatment of patients with metastatic neuroblastoma is increasingly evident. The idiotype network appears to represent one component of a complex mechanism for success with mAb-based immunotherapy. Ongoing strategies to modify or reconstruct mAbs, to engage them with cytokines, or to unite them with T cells open new avenues for harnessing the unique forces of the immune system against some of the most deadly pediatric cancers.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11765377     DOI： 10.1016/s0889-8588(05)70255-0

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  9 in total

1.  Anti-GD2 Strategy in the Treatment of Neuroblastoma.

Authors:  Richard K Yang; Paul M Sondel
Journal:  Drugs Future       Date:  2010       Impact factor: 0.148

Review 2.  Stem cell transplantation for neuroblastoma.

Authors:  J D Fish; S A Grupp
Journal:  Bone Marrow Transplant       Date:  2007-11-26       Impact factor: 5.483

Review 3.  Neuroblastoma: issues in transplantation.

Authors:  Stephan A Grupp; Shahab Asgharzadeh; Gregory A Yanik
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

Review 4.  Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.

Authors:  David Barrett; Jonathan D Fish; Stephan A Grupp
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

5.  RESEARCH ADVANCES IN NEUROBLASTOMA IMMUNOTHERAPY.

Authors:  Latania Y Booker; Titilope A Ishola; Kanika A Bowen; Dai H Chung
Journal:  Curr Pediatr Rev       Date:  2009-05

6.  Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells.

Authors:  Chun-Yen Tsao; Francesco Sabbatino; Nai-Kong V Cheung; Jeff Chi-Feng Hsu; Vincenzo Villani; Xinhui Wang; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

7.  Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.

Authors:  Shahab Asgharzadeh; Jill A Salo; Lingyun Ji; André Oberthuer; Matthias Fischer; Frank Berthold; Michael Hadjidaniel; Cathy Wei-Yao Liu; Leonid S Metelitsa; Roger Pique-Regi; Peter Wakamatsu; Judith G Villablanca; Susan G Kreissman; Katherine K Matthay; Hiroyuki Shimada; Wendy B London; Richard Sposto; Robert C Seeger
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

8.  Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients.

Authors:  Juan C Gutierrez; Anne C Fischer; Juan E Sola; Eduardo A Perez; Leonidas G Koniaris
Journal:  Pediatr Surg Int       Date:  2007-05-03       Impact factor: 2.003

9.  Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study.

Authors:  Ji Won Lee; Sanghoon Lee; Hee Won Cho; Youngeun Ma; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo; Eun Joo Cho; Suk-Koo Lee; Do Hoon Lim
Journal:  J Hematol Oncol       Date:  2017-05-16       Impact factor: 17.388
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.